Latest News & Features
Americas
Swiss pharmaceutical company Novartis can buy London-based GlaxoSmithKline’s portfolio of cancer drugs after it agreed to meet certain conditions set by the US Federal Trade Commission, the agency has said. 24 February 2015
Americas
Pharmaceutical companies Teva, Momenta, Mylan and Sandoz have asked the US Court of Appeals for the Federal Circuit for an expedited ruling on the validity of Teva’s patent covering its Copaxone drug. 23 February 2015
Americas
Molecular diagnostic company Myriad Genetics has settled the last of its seven BRCA-related patent disputes in the US, this time with genetic testing company GeneDx. 20 February 2015
Big Pharma
The Court of Justice of the European Union has clarified when pharmaceutical patent owners may rely on the Specific Mechanism to prevent parallel imports of their products. 19 February 2015
article
Two years after its launch, the LSIPR monthly is having a re-brand. This issue will be the final one published in a PDF format, as in March we are switching to a ‘digital first’ strategy. 19 February 2015
Big Pharma
A US court has ruled that an AstraZeneca patent covering asthma inhaler Pulmicort Respules is invalid, allowing generic drug makers to enter the market with their own versions. 17 February 2015
Americas
The Canadian government has given a scathing assessment of Eli Lilly’s patenting practices in its formal response to the pharmaceutical company’s CAD $500 million lawsuit against it. 16 February 2015
Genetics
The High Court of Australia is set to consider the Myriad Genetics case concerning whether isolated genetic material is patentable subject matter. 16 February 2015
Americas
Law firm Kaye Scholer has added a team of three life sciences and technology lawyers to its intellectual property group. 13 February 2015
Americas
Novartis has sued drug company BPI Labs for alleged patent infringement after it requested permission to market a generic version of Novartis’s bone cancer drug Zometa. 12 February 2015